HLS Therapeutics, Inc. (HLS.TO)

4.50 0.00 (0.00%) CAD  |  TSX  |  Feb 20, 16:00
More

HLS Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for HLS.TO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Arch Biopartners, Inc. Upgrade
Biocure Technology, Inc. Upgrade
Resverlogix Corp. Upgrade
Microbix Biosystems, Inc. Upgrade
Theratechnologies, Inc. Upgrade